These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Seroprevalence of rubella among Jordanian women of childbearing age. Jarour N, Hayajneh WA, Balbeesi A, Otoom H, Al-Shurman A, Kharabsheh S. Vaccine; 2007 May 04; 25(18):3615-8. PubMed ID: 17280747 [Abstract] [Full Text] [Related]
6. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran. Soleimanjahi H, Bamdad T, Fotouhi F, Roustai MH, Faghihzadeh S. J Clin Virol; 2005 Oct 04; 34(2):153-4. PubMed ID: 16076562 [Abstract] [Full Text] [Related]
7. [Susceptibility of pregnant women to rubella and the implications of immunization programs]. Villalbí JR, Graells C, Marín T. An Esp Pediatr; 1988 Feb 04; 28(2):137-40. PubMed ID: 3355032 [Abstract] [Full Text] [Related]
8. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan. Tseng HF, Chang CK, Tan HF, Yang SE, Chang HW. Vaccine; 2006 Jul 17; 24(29-30):5772-7. PubMed ID: 16759764 [Abstract] [Full Text] [Related]
15. [Immune response of rubella vaccine in the populations with different age groups]. Xiong XW, Diao LD, Yan XL. Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug 17; 18(4):227-9. PubMed ID: 9812525 [Abstract] [Full Text] [Related]
16. Prevalence of rubella-specific IgG antibody in non-immunized pregnant women in Maiduguri, north eastern Nigeria. Bukbuk DN, el Nafaty AU, Obed JY. Cent Eur J Public Health; 2002 Jun 17; 10(1-2):21-3. PubMed ID: 12096678 [Abstract] [Full Text] [Related]
19. Rubella immune status of pregnant and non-pregnant women in Istanbul, Turkey. Seker S, Abasiyanik MF, Salih BA. Saudi Med J; 2004 May 17; 25(5):575-9. PubMed ID: 15138523 [Abstract] [Full Text] [Related]